Literature DB >> 29023876

MRI assessment of treatment delivery for interstitial photodynamic therapy of high-grade glioma in a preclinical model.

Henri-Arthur Leroy1,2, Maximilien Vermandel1, Bertrand Leroux1, Alain Duhamel3, Jean-Paul Lejeune1,2, Serge Mordon1, Nicolas Reyns1,2.   

Abstract

BACKGROUND: High-grade gliomas are primary brain tumors that have shown increasing incidence and unfavorable outcomes. Local control is crucial to the management of this pathology. Photodynamic therapy (PDT), based on the light-induced activation of a photosensitizer (PS), achieves local treatment by inducing selective lesions in tumor tissue.
OBJECTIVES: Previous studies have reported the outcomes of PDT for glioblastoma via immunohistological data. Our study aimed to evaluate MRI findings, including diffusion, and perfusion sequences, compared with immunohistological data from the same population to address the efficiency of light fractionation.
MATERIALS AND METHODS: Twenty-six "nude" rats grafted with human U87 cells into the right putamen underwent PDT. After PS precursor (5-ALA) intake, an optical fiber was introduced into the tumor. The rats were randomized into the following groups: those without illumination and those that received two or five fractions of light. Treatment effects were assessed with early high-field MRI to measure the volume of necrosis and edema using diffusion and perfusion sequences; the MRI results were compared with immunohistology results, including necrosis and apoptosis markers.
RESULTS: Elevated diffusion values were observed on MRI in the centers of the tumors of the treated animals, especially in the 5-fraction group (P < 0.01). Perfusion was decreased around the treatment site, especially in the 5-fraction group (P = 0.024). The MRI findings were consistent with previously published histological data. The median volume of necrosis was significantly different between the sham group and treated groups, 0 mm3 versus 2.67 mm3 , P < 0.001. The same trend was previously observed in histology data when grading the absence or presence of necrosis and when the presence of necrosis was significantly more predominant for the treated group than for the untreated group (P < 001). Additionally, cell death represented by apoptosis marker data (TUNEL method) was significantly higher in the 5-fraction group than in the 2-fraction group (P = 0.01).
CONCLUSION: Diffusion and perfusion MRI revealed histological lesions. Interstitial PDT (iPDT) induced specific lesions in the tumor tissue, which were observed with MRI and confirmed by histopathological analysis. Thus, MRI may provide a non-invasive and reliable tool to assess treatment outcomes after PDT. Lasers Surg. Med. 50:460-468, 2018.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  5-ALA; MRI; PDT; PpIX; glioblastoma; high-grade glioma; magnetic resonance imaging; photodynamic therapy

Mesh:

Substances:

Year:  2017        PMID: 29023876     DOI: 10.1002/lsm.22744

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  3 in total

1.  Oxygen saturation imaging as a useful tool for visualizing the mode of action of photodynamic therapy for esophageal cancer.

Authors:  Masayuki Suyama; Yusuke Yoda; Yoichi Yamamoto; Hironori Sunakawa; Tatsunori Minamide; Keisuke Hori; Hiroaki Ikematsu; Tomonori Yano
Journal:  VideoGIE       Date:  2020-08-07

2.  Improved MR thermometry for laser interstitial thermotherapy.

Authors:  Henrik Odéen; Dennis L Parker
Journal:  Lasers Surg Med       Date:  2019-01-15       Impact factor: 4.025

3.  Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial.

Authors:  Maximilien Vermandel; Clément Dupont; Fabienne Lecomte; Henri-Arthur Leroy; Constantin Tuleasca; Serge Mordon; Constantinos G Hadjipanayis; Nicolas Reyns
Journal:  J Neurooncol       Date:  2021-03-20       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.